PCDH10 and pancreatic ductal adenocarcinoma: Recently, high methylation levels of Pcdh10 were found to correlate with worse progression-free survival rates instead of the overall survival, suggesting that Pcdh10 methylation status predicts poor prognosis in patients with pancreatic ductal adenocarcinomas (Curia et al. 2019).